Atlas Trials

Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome

Clinical trial NCT04137692 · SUSPENDED

Trial details

NCT number
NCT04137692
Sponsor
Weill Medical College of Cornell University
Status
SUSPENDED
Phase
Not Applicable
Study type
INTERVENTIONAL
Glucose Transporter Type 1 Deficiency SyndromeGLUT1DS1
Start date
2027-09-01
Primary completion
2030-08-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.